Some patients see excellent results on semaglutide's single GLP-1 pathway, while others show stronger weight loss and metabolic improvements when both GLP-1 and GIP receptors are activated
Amid spotty access to semaglutide (brand names, Ozempic and Wegovy), people seeking the injectable drug for weight loss have begun ordering it from alleged doctors on TikTok, online pharmacies, medical spas, and compounding pharmacies peddling nonexistent "generic" versions of the drug
That matters because both estrogen deficiency and polycystic ovary syndrome (PCOS) can make it easier to store fat in the liver
As those litigations wrap up, it is possible that we could see additional patent infringement claims brought against entities making and selling compounded versions of the drugs
Jonathan Taylor Thursday, September 17 6:00 PM - 7:00 PM View event details Weight Loss Weight Loss Surgery Seminar - Dr